| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | XENOPORT INC | 1,100,000 | 4,961,000 | 0.42% | ||
| 52 | Ascendis Pharma | 270,000 | 5,009,000 | 0.42% | ||
| 53 | AMICUS THERAPEUTICS INC COM | 613,500 | 5,184,000 | 0.43% | ||
| 54 | INTRA-CELLULAR THERAPIES INC | 187,500 | 5,213,000 | 0.44% | ||
| 55 | ADURO BIOTECH INC | 415,000 | 5,316,000 | 0.45% | ||
| 56 | CHINA CORD BLOOD CORP | 880,000 | 5,342,000 | 0.45% | ||
| 57 | ENVISION HEALTHCARE HLDGS INC | 266,000 | 5,426,000 | 0.45% | ||
| 58 | INSMED INC | 450,000 | 5,702,000 | 0.48% | ||
| 59 | INSYS THERAPEUTICS INC NEW COM NEW | 365,500 | 5,844,000 | 0.49% | ||
| 60 | FIVE PRIME THERAPEUTICS INC | 144,500 | 5,871,000 | 0.49% | ||
| 61 | REGENERON PHARMACEUTICALS | 16,500 | 5,947,000 | 0.50% | ||
| 62 | COHERUS BIOSCIENCES INC COM | 282,000 | 5,987,000 | 0.50% | ||
| 63 | DERMIRA INC COM | 290,000 | 5,997,000 | 0.50% | ||
| 64 | Heartware International, Inc. | 193,000 | 6,064,000 | 0.51% | ||
| 65 | NOVADAQ TECHNOLOGIES INC | 555,000 | 6,155,000 | 0.52% | ||
| 66 | ADAPTIMMUNE THERAPEUTICS PLC | 765,001 | 6,219,000 | 0.52% | ||
| 67 | ATHENA HEALTH INC. | 45,750 | 6,349,000 | 0.53% | ||
| 68 | Intersect ENT Inc | 340,000 | 6,460,000 | 0.54% | ||
| 69 | BEIGENE LTD | 225,000 | 6,595,000 | 0.55% | ||
| 70 | CORVUS PHARMACEUTICALS INC COM | 456,887 | 6,625,000 | 0.56% | ||
| 71 | ALKERMES PLC | 194,500 | 6,650,000 | 0.56% | ||
| 72 | VERTEX PHARMACEUTICALS INC | 83,900 | 6,669,000 | 0.56% | ||
| 73 | EDWARDS LIFESCIENCES CORP | 76,000 | 6,704,000 | 0.56% | ||
| 74 | SERES THERAPEUTICS INC | 262,000 | 6,959,000 | 0.58% | ||
| 75 | RETROPHIN INC | 521,400 | 7,122,000 | 0.60% | ||
| 76 | EPIZYME INC COM | 589,000 | 7,139,000 | 0.60% | ||
| 77 | COOPER COS INC | 47,600 | 7,329,000 | 0.61% | ||
| 78 | RTI SURGICAL HOLDINGS INC COM | 1,860,000 | 7,440,000 | 0.62% | ||
| 79 | ULTRAGENYX PHARMACEUTICAL INC COM | 118,500 | 7,502,000 | 0.63% | ||
| 80 | JUNO THERAPEUTICS INC COM | 197,001 | 7,504,000 | 0.63% | ||
| 81 | INVITAE CORP | 752,500 | 7,698,000 | 0.64% | ||
| 82 | HEALTHSOUTH CORP | 208,000 | 7,827,000 | 0.66% | ||
| 83 | INOVALON HLDGS INC COM CL A | 427,300 | 7,914,000 | 0.66% | ||
| 84 | Wright Medical Group NV | 490,000 | 8,134,000 | 0.68% | ||
| 85 | ARDELYX INC COM | 1,060,400 | 8,239,000 | 0.69% | ||
| 86 | BIOMARIN PHARMACEUTICAL INC | 103,250 | 8,516,000 | 0.71% | ||
| 87 | GALAPAGOS NV | 210,000 | 8,782,000 | 0.74% | ||
| 88 | ACHILLION PHARMACEUTICALS IN | 1,220,000 | 9,418,000 | 0.79% | ||
| 89 | INCYTE CORP | 130,500 | 9,457,000 | 0.79% | ||
| 90 | Anacor Pharmaceuticals Inc | 177,500 | 9,487,000 | 0.79% | ||
| 91 | THERAPEUTICSMD INC | 1,575,000 | 10,080,000 | 0.84% | ||
| 92 | WALGREENS BOOTS ALLIANCE INC | 123,500 | 10,404,000 | 0.87% | ||
| 93 | PENUMBRA INC COM | 228,500 | 10,511,000 | 0.88% | ||
| 94 | GW PHARMACEUTICALS PLC | 147,000 | 10,606,000 | 0.89% | ||
| 95 | PRA HEALTH SCIENCES INC | 253,000 | 10,818,000 | 0.91% | ||
| 96 | BRISTOL MYERS SQUIBB CO | 170,000 | 10,860,000 | 0.91% | ||
| 97 | JAZZ PHARMACEUTICALS PLC | 85,500 | 11,162,000 | 0.94% | ||
| 98 | MCKESSON CORP | 77,500 | 12,187,000 | 1.02% | ||
| 99 | Theravance Biopharma Inc | 650,500 | 12,229,000 | 1.02% | ||
| 100 | MEDNAX INC | 195,000 | 12,601,000 | 1.06% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003409, filed 2016.05.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
